Events

Marie Skłodowska-Curie Actions Staff Exchanges 2022 call Info Session
DEC
Wed
07
10:30 - 12:30

This was 3 years ago

Location

virtual

Programmes
MSCA

The Directorate General for Education, Youth, Sport & Culture (EAC) of the European Commission and the European Research Executive Agency (EREA) organise a web-streamed info session, dedicated to the 2022 MSCA Staff Exchanges call for proposals. Participants will receive key information on the main features and impact of the Staff Exchanges Action and the application process.

Programme

10:30 - 10:45 Welcome and opening remarks

10:45 - 11:00 MSCA Policy context

11:00 - 11:30 Cooperation between business and academia: Live discussion

11:30 - 12:10 All you need to know about Staff Exchanges

12:10 - 12:25 Q&A (Slido)

12:25 - 12:30 Closing of event

Recording

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.